{
    "title": "Reversing abortion drug's approval would harm public interest, U.S. FDA says",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11645291/Reversing-abortion-drugs-approval-harm-public-U-S-FDA-says.html",
    "date": "2023-01-17",
    "keywords": [
        "abortion",
        "drug",
        "fda",
        "medication",
        "mifepristone",
        "court",
        "brendan",
        "pierson",
        "jan",
        "administration",
        "judge",
        "request",
        "approval",
        "filing",
        "lawsuit",
        "texas",
        "antiabortion",
        "mifeprex",
        "pregnancy",
        "agency",
        "president",
        "joe",
        "order",
        "half",
        "food",
        "district",
        "matthew",
        "kacsmaryk",
        "online",
        "tuesday",
        "interest",
        "marketplace",
        "market",
        "amarillo",
        "lawyer",
        "comment",
        "brand",
        "name",
        "generic",
        "conjunction",
        "government",
        "time",
        "attention",
        "june",
        "landmark",
        "roe",
        "wade",
        "decision",
        "november",
        "guttmacher",
        "institute",
        "research",
        "group",
        "alliance",
        "medicine",
        "association",
        "prolife",
        "process",
        "basis",
        "judgment",
        "wait",
        "support",
        "argument",
        "example",
        "maine",
        "family",
        "planning",
        "maker",
        "danco",
        "friday",
        "ability",
        "reporting",
        "york",
        "editing",
        "garamfalvi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}